Avecho Biotechnology (ASX:AVE)
ASX announcement history & article coverage
Transparent by design.
Announcments by Avecho Biotechnology (ASX:AVE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Avecho enters final stage of Phase III insomnia trial
Avecho restarts recruitment for final Phase III insomnia trial after positive interim results
Notification regarding unquoted securities - AVE
Appendix 4D and Half-year Financial Report
Avecho strengthens BD capability with senior appointment
Small Holding Share Sale Facility Completion
Japanese patent granted for CBD capsule
June 2026 Quarterly Activities Report & Appendix 4C
Avecho reports positive Phase III insomnia trial interim results and strengthens financial position
Application for quotation of securities - AVE
Positive Phase III Interim Analysis Results Investor Webinar
Positive interim results from Phase III insomnia program
Phase III Interim Analysis Outcome Webinar
Trading Halt